Skip to content

Anaheal plus supplement in contact dermatitis

Assessment of the therapeutic effects of Anaheal plus supplement in patients with contact dermatitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150706023084N16
Enrollment
50
Registered
2023-08-21
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritant contact dermatitis. Irritant contact dermatitis, unspecified cause

Interventions

Intervention 1: Intervention group: including 25 patients who are diagnosed with contact dermatitis by a dermatologist and consume Anahil Plus supplement produced by the company (two tablets daily) pl

Sponsors

Parmoon Salamat Amin Pharmaceutical Company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients (over 12 years old) Patient with contact dermatitis

Exclusion criteria

Exclusion criteria: Allergy to pineapple, celery, carrot and fennel having hemophilia taking two anti-platelet drugs or one anti-platelet drug and an anticoagulant severe kidney failure (GFR<30) severe liver failure (Child pugh B, C) Pregnancy lactation

Design outcomes

Primary

MeasureTime frame
The surface of the affected area. Timepoint: 30 days. Method of measurement: Measuring with a ruler.;Redness. Timepoint: 30 days. Method of measurement: According to REEDA.;Edema. Timepoint: 30 days. Method of measurement: According to REEDA.;Itching. Timepoint: 30 days. Method of measurement: Ask the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Shiehmorteza

Islamic Azad University

Shiehmorteza@iaups.ac.ir+98 21 2264 0056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026